5:07 PM
 | 
Aug 26, 2013
 |  BC Extra  |  Top Story

Amgen acquiring Onyx

Amgen Inc. (NASDAQ:AMGN) jumped $8.15 to $113.75 on Monday after it and Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) said Amgen will acquire the cancer company for $125 per share in cash, or about $10.4 billion including Onyx's cash. Onyx markets multiple myeloma drug...

Read the full 191 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >